INTRODUCING IPS: A PROGNOSTIC BIOMARKER FOR PATIENTS ON ICI THERAPY /// LEARN MORE INTRODUCING IPS: A PROGNOSTIC BIOMARKER FOR PATIENTS ON ICI THERAPY /// LEARN MORE

Leadership Team

Eric Lefkofsky Founder & CEO

Read Bio

Christina Antoniou Senior Vice President, Head of Corporate Development

Read Bio

Nike Beaubier, MD Senior Vice President, Life Science Pathology

Read Bio

Terron Bruner Chief Commercial Officer

Read Bio

Ezra Cohen, MD Chief Medical Officer of Oncology

Read Bio

Shane Colley Chief Technology Officer

Read Bio

Robyn Eckerling Chief Privacy Officer

Read Bio

Laura Elster Senior Vice President, Healthcare Innovation & Transformation

Read Bio

Greg Fisbeck Chief Information Security Officer

Read Bio

Ryan Fukushima Chief Operating Officer

Read Bio

Amy Gordon Franzen Senior Vice President of Trials

Read Bio

Stacey Kraft Chief People Officer

Read Bio

Andy Moye, PhD SVP & GM, Data Products

Read Bio

Halla Nimeiri, MD Chief Development Officer

Read Bio

Phil Perez Senior Vice President, Commercial Life Sciences

Read Bio

Erik Phelps EVP and Chief Administrative and Legal Officer

Read Bio

Andy Polovin General Counsel

Read Bio

Jim Rogers Chief Financial Officer

Read Bio

Kate Sasser, PhD Chief Scientific Officer

Read Bio

Chris Scotto DiVetta Senior Vice President & General Manager of AI

Read Bio

Lauren Silvis Senior Vice President of External Affairs

Read Bio

Patty Spiller Senior Vice President of Marketing

Read Bio

Shane Woods, PhD Chief Strategy Officer

Read Bio

Mike Yasiejko Executive Vice President and General Manager, Genomics

Read Bio

Directors

“We are thrilled to have led an investment in Tempus... Given NEA's long and successful history investing in the intersection of technology and life science, we felt like the perfect strategic partner given Tempus' mission to help doctors personalize care by collecting and analyzing large volumes of data.”

Peter Barris, Chairman & General Partner, New Enterprise Associates

“The next major evolution in health care will be the embrace of data to dramatically improve patient outcomes, and I believe Tempus is the company that is best positioned to lead this transition. The team at Tempus is exceptional, and as committed to the mission as can be.”

Eric Belcher, Chief Executive Officer, Numerator

“I look forward to working with the Tempus team as they continue to apply technology and artificial intelligence to healthcare, deploying intelligent diagnostics that enhance research, empower physicians, and positively change the lives of patients.”

Jennifer Doudna, PhD, Li Ka Shing Chancellor’s Professor of Biomedical Science, University of California, Berkeley and Founder, Innovative Genomics Institute

“Tempus has developed a distinct set of solutions that has real potential to revolutionize cancer care. I look forward to working with the leadership team in developing those offerings to provide even more value to the company, its partners, and ultimately patients.”

David R. Epstein, Former Chief Executive Officer, Seagen

“As a surgical oncologist, I have worked to reduce racial, ethnic and gender health care disparities throughout my career. Tempus is a leader in the field of data-driven medicine, and I am excited to work with their team to further enhance patient outcomes for individuals of all backgrounds and from all communities.”

Wayne A. I. Frederick, MD, MBA, Charles R. Drew Professor of Surgery

“I'm honored to be working with the Tempus team as they advance innovative tools for personalizing patient care and empower providers with information that can help them make better and more informed treatment decisions for their patients.”

Scott Gottlieb, MD, Scientific Advisor

“Having spent my entire career at the forefront of emerging technologies, it’s exciting to see how healthcare is finally embracing the very technologies that have transformed so many other industries. This is a space that is near and dear to me, and I'm excited to be a part of Tempus as they seek to bring big data, artificial intelligence and advanced molecular analysis to those suffering with cancer and other life threatening diseases.”

Ted Leonsis, Cofounder & Partner, Revolution Growth

"It is an honor to serve with the Tempus team — professionals with a passion to transform healthcare through technology that facilitates patients rapidly getting the best treatment available for their unique situations; to relieve their suffering, improve their health and save their lives.”

Nadja West, LTG (ret), MD, 44th U.S. Army Surgeon General

Scientific Advisors

David Agus, MD Scientific Advisor

Read Bio

Funmi Olopade, MD Scientific Advisor

Read Bio

Norman E. Sharpless, MD Senior Strategic Advisor

Read Bio

Eric Topol, MD Scientific Advisor

Read Bio